ENTRY       K04377                      KO
NAME        MYC
DEFINITION  Myc proto-oncogene protein
PATHWAY     ko04010  MAPK signaling pathway
            ko04012  ErbB signaling pathway
            ko04110  Cell cycle
            ko04151  PI3K-Akt signaling pathway
            ko04310  Wnt signaling pathway
            ko04350  TGF-beta signaling pathway
            ko04390  Hippo signaling pathway
            ko04391  Hippo signaling pathway - fly
            ko04630  Jak-STAT signaling pathway
            ko04919  Thyroid hormone signaling pathway
            ko05161  Hepatitis B
            ko05166  HTLV-I infection
            ko05169  Epstein-Barr virus infection
            ko05200  Pathways in cancer
            ko05202  Transcriptional misregulation in cancer
            ko05205  Proteoglycans in cancer
            ko05206  MicroRNAs in cancer
            ko05210  Colorectal cancer
            ko05213  Endometrial cancer
            ko05216  Thyroid cancer
            ko05219  Bladder cancer
            ko05220  Chronic myeloid leukemia
            ko05221  Acute myeloid leukemia
            ko05222  Small cell lung cancer
DISEASE     H00001  Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia)
            H00002  Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia)
            H00008  Burkitt lymphoma
            H00010  Multiple myeloma
            H00013  Small cell lung cancer
            H00016  Oral cancer
            H00025  Penile cancer
            H00027  Ovarian cancer
            H00028  Choriocarcinoma
            H00031  Breast cancer
            H00036  Osteosarcoma
            H00041  Kaposi's sarcoma
            H00055  Laryngeal cancer
BRITE       KEGG Orthology (KO) [BR:ko00001]
             Environmental Information Processing
              Signal transduction
               04010 MAPK signaling pathway
                K04377  MYC; Myc proto-oncogene protein
               04012 ErbB signaling pathway
                K04377  MYC; Myc proto-oncogene protein
               04310 Wnt signaling pathway
                K04377  MYC; Myc proto-oncogene protein
               04350 TGF-beta signaling pathway
                K04377  MYC; Myc proto-oncogene protein
               04390 Hippo signaling pathway
                K04377  MYC; Myc proto-oncogene protein
               04391 Hippo signaling pathway -fly
                K04377  MYC; Myc proto-oncogene protein
               04630 Jak-STAT signaling pathway
                K04377  MYC; Myc proto-oncogene protein
               04151 PI3K-Akt signaling pathway
                K04377  MYC; Myc proto-oncogene protein
             Cellular Processes
              Cell growth and death
               04110 Cell cycle
                K04377  MYC; Myc proto-oncogene protein
             Organismal Systems
              Endocrine system
               04919 Thyroid hormone signaling pathway
                K04377  MYC; Myc proto-oncogene protein
             Human Diseases
              Cancers
               05200 Pathways in cancer
                K04377  MYC; Myc proto-oncogene protein
               05202 Transcriptional misregulation in cancers
                K04377  MYC; Myc proto-oncogene protein
               05206 MicroRNAs in cancer
                K04377  MYC; Myc proto-oncogene protein
               05205 Proteoglycans in cancer
                K04377  MYC; Myc proto-oncogene protein
               05210 Colorectal cancer
                K04377  MYC; Myc proto-oncogene protein
               05216 Thyroid cancer
                K04377  MYC; Myc proto-oncogene protein
               05221 Acute myeloid leukemia
                K04377  MYC; Myc proto-oncogene protein
               05220 Chronic myeloid leukemia
                K04377  MYC; Myc proto-oncogene protein
               05219 Bladder cancer
                K04377  MYC; Myc proto-oncogene protein
               05213 Endometrial cancer
                K04377  MYC; Myc proto-oncogene protein
               05222 Small cell lung cancer
                K04377  MYC; Myc proto-oncogene protein
              Infectious diseases
               05166 HTLV-I infection
                K04377  MYC; Myc proto-oncogene protein
               05161 Hepatitis B
                K04377  MYC; Myc proto-oncogene protein
               05169 Epstein-Barr virus infection
                K04377  MYC; Myc proto-oncogene protein
            Transcription factors [BR:ko03000]
             Eukaryotic Type
              Basic helix-loop-helix/leucine zipper (bHLH-ZIP)
               Cell cycle controlling factors, Myc
                K04377  MYC; Myc proto-oncogene protein
GENES       HSA: 4609(MYC)
            PTR: 464393(MYC)
            PPS: 100972175(MYC)
            GGO: 101137026(MYC)
            PON: 100456735(MYC)
            MCC: 694626(MYC)
            MCF: 102127966(MYC)
            MMU: 17869(Myc)
            RNO: 24577(Myc)
            CGE: 100758352 100773301
            HGL: 101704740 101727564
            TUP: 102501999
            CFA: 403924(MYC)
            AML: 100464396
            FCA: 100379628(MYC)
            PTG: 102954147(MYC)
            BTA: 511077(MYC)
            BOM: 102274304(MYC)
            PHD: 102328645
            CHX: 102171262(MYC)
            SSC: 448810(MYC)
            CFR: 102511086
            BACU: 103016933(MYC)
            LVE: 103089962(MYC)
            ECB: 100068097(MYC)
            MYB: 102257498(MYC)
            MYD: 102758544(MYC)
            PALE: 102895524
            MDO: 100032344(MYC)
            SHR: 100921308(MYC)
            OAA: 100079391(MYC)
            GGA: 420332(MYC)
            MGP: 100547931
            TGU: 100219849
            FAB: 101819732(MYC)
            PHI: 102108851(MYC)
            APLA: 101803370(MYC)
            FPG: 101923426(MYC)
            FCH: 102056832(MYC)
            CLV: 102085948(MYC)
            ASN: 102370393(MYC)
            AMJ: 102561083
            PSS: 102449445(MYC)
            CMY: 102943256(MYC)
            ACS: 100558533
            PBI: 103057606
            XLA: 379052(myc-a) 399315(myc)
            XTR: 395024
            DRE: 393141(mycb)
            TRU: 653028(c-myc)
            MZE: 101464606 101474120 101479046
            OLA: 101164933 101171524(c-myc17)
            XMA: 102220374 102224917 102229551
            LCM: 102357079(MYC) 102359985
            CMK: 103173257 103185113(myc)
            BFO: BRAFLDRAFT_60197
            SPU: 373385
            DME: Dmel_CG10798(dm)
            DPO: Dpse_GA10565
            DAN: Dana_GF19606
            DER: Dere_GG18655
            DPE: Dper_GL13122
            DSE: Dsec_GM19268
            DSI: Dsim_GD16640
            DWI: Dwil_GK24977
            DYA: Dyak_GE16299
            DGR: Dgri_GH12538
            DMO: Dmoj_GI14431
            DVI: Dvir_GJ18771
            AGA: AgaP_AGAP000646
            CQU: CpipJ_CPIJ009795
            NVI: 100679741
            BMOR: 100862782(myc)
            PHU: Phum_PHUM566250
            ISC: IscW_ISCW023000
            NVE: NEMVE_v1g178332
            HMG: 100199110(myc2)
            TAD: TRIADDRAFT_57914
            AQU: 100636430
            MBR: MONBRDRAFT_33423(MbMyc)
REFERENCE   PMID:20399964
  AUTHORS   Albihn A, Johnsen JI, Henriksson MA
  TITLE     MYC in oncogenesis and as a target for cancer therapies.
  JOURNAL   Adv Cancer Res 107:163-224 (2010)
///
